Updates to Health AI Register March 2024


Icometrix has reveiced MDR clearance for icobrain ms, icobrain dm, icobrain tbi, icobrain ep, and icobrain cva. All four products are classified as class IIa.

MRIguidance has upgraded their MDR compliance for visualization of the total spine, (including cervical, thoracic and lumbar spine), and the pelvic region.

Blackford adds Pixyl and Radiobotics to their portfolio.

Avicenna.AI receives FDA clearance for two of its products: CINA-iPE; a triage tool for incidental pulmonary embolism detection and CINA-ASPECTS for automated ASPECTS scoring. With these latest additions, the whole portfolio of Avicenna.AI is now available in both the EU and US.

Several biomarker modules from Quibim have been removed from Health AI Register as they are no longer, as such, offered for clinical use. It regards: Diffusion Weighted Imaging (DWI) - ADC, Diffusion Weighted Imaging (DWI) - IVIM, Perfusion pharmacokinetics modeling, Liver Fat & Iron Concentration, Lung densities, Bone microarchitecture 3D, Bone microarchitecture 2D, Texture analysis, T2 Mapping (relaxometry), Chest X-Ray Classifier.